FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Toshikazu Yamanouchi

Research Profile

Chemicals & Drugs

Disorders

Phenomena

Isomerism

Concepts & Ideas

Living Beings

Rats

Co-author Network

Publications

TOP 3
Takahiro Kawasaki; Nobuyuki Ogata; Yoko Oka; Kaoru Ichiyanagi; Kanji Igarashi; Toshikazu Yamanouchi
Markedly increased serum and urinary fructose concentrations in diabetic patients with ketoacidosis or ketosis.
Kyoko Nomura; Toshikazu Yamanouchi
The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
Yoshiki Miyata; Haruyuki Tanaka; Arata Shimada; Takashi Sato; Akira Ito; Toshikazu Yamanouchi; Hiroshi Kosano
Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Toshikazu Yamanouchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Takahiro Kawasaki; Nobuyuki Ogata; Yoko Oka; Kaoru Ichiyanagi; Kanji Igarashi; Toshikazu Yamanouchi
Markedly increased serum and urinary fructose concentrations in diabetic patients with ketoacidosis or ketosis.
Acta diabetologica 2012;49(2):119-23.
2012: Kyoko Nomura; Toshikazu Yamanouchi
The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
The Journal of nutritional biochemistry 2012;23(3):203-8.
2011: Yoshiki Miyata; Haruyuki Tanaka; Arata Shimada; Takashi Sato; Akira Ito; Toshikazu Yamanouchi; Hiroshi Kosano
Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin.
Life sciences 2011;88(13-14):613-8.
2011: Kyoko Nomura; Tomoyuki Saitoh; Gwang U Kim; Toshikazu Yamanouchi
Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c.
ISRN endocrinology 2011;2011():435047.
2010: Toshikazu Yamanouchi
[Anti glutamic acid decarboxylase (GAD) antibody].
Nihon rinsho. Japanese journal of clinical medicine 2010;68 Suppl 7():594-6.
2010: Toshikazu Yamanouchi
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes.
Vascular health and risk management 2010;6():189-97.
2007: Kyoko Nomura; Toshikazu Yamanouchi; Gwang U Kim; Kazuhiro Ohwaki; Eiji Yano
Impact of glucose intolerance on coronary calcified lesions evaluated using multislice computed tomography.
The Tohoku journal of experimental medicine 2007;212(2):107-13.
2006: Toshikazu Yamanouchi
[Thiazolidinediones].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 9():633-6.
2005: Toshikazu Yamanouchi
[Anti GAD (glutamic acid decarboxylase) antibody].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 8():555-7.
2005: Toshikazu Yamanouchi; Tadashi Sakai; K Igarashi; Kaoru Ichiyanagi; Hiroyuki Watanabe; Takahiro Kawasaki
Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(8):980-5.
2005: Takahiro Kawasaki; Akiko Kashiwabara; Tadashi Sakai; Kanji Igarashi; Nobuyuki Ogata; Hiroyuki Watanabe; Kaoru Ichiyanagi; Toshikazu Yamanouchi
Long-term sucrose-drinking causes increased body weight and glucose intolerance in normal male rats.
The British journal of nutrition 2005;93(5):613-8.
2004: Toshikazu Yamanouchi
[Myoinositol].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 11():670-2.
2004: Toshikazu Yamanouchi
[1,5-anhydroglucitol].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 11():667-9.
2004: Takahiro Kawasaki; Nobuyuki Ogata; Hiroshi Akanuma; Tadashi Sakai; Hiroyuki Watanabe; Kaoru Ichiyanagi; Toshikazu Yamanouchi
Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes.
Metabolism: clinical and experimental 2004;53(5):583-8.
2003: Toshikazu Yamanouchi; Tae Inoue; Kaoru Ichiyanagi; Tadashi Sakai; Nobuyuki Ogata
1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines.
Biochimica et biophysica acta 2003;1623(2-3):82-7.
2003: N Sekino; Akiko Kashiwabara; Tomomi Inoue; Takahiro Kawasaki; Nobuyuki Ogata; K Sawashige; Toshikazu Yamanouchi
Usefulness of troglitazone administration to obese hyperglycaemic patients with near-normoglycaemia.
Diabetes, obesity & metabolism 2003;5(3):145-9.
2003: Toshikazu Yamanouchi
[Tophaceous gout].
Nihon rinsho. Japanese journal of clinical medicine 2003;61 Suppl 1():219-23.
2003: Toshikazu Yamanouchi
[Gouty arthritis].
Nihon rinsho. Japanese journal of clinical medicine 2003;61 Suppl 1():213-8.
2002: Takahiro Kawasaki; Hiroshi Akanuma; Toshikazu Yamanouchi
Increased fructose concentrations in blood and urine in patients with diabetes.
Diabetes care 2002;25(2):353-7.
2001: Toshikazu Yamanouchi
[KRP-297, MCC-555].
Nihon rinsho. Japanese journal of clinical medicine 2001;59(11):2200-6.
2001: Toshikazu Yamanouchi; Tomomi Inoue; E Ogata; Akiko Kashiwabara; Nobuyuki Ogata; N Sekino; T Yoshimura; Kaoru Ichiyanagi; Takahiro Kawasaki
Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance.
Clinical science (London, England : 1979) 2001;101(3):227-33.
2000: Takahiro Kawasaki; Toshikazu Yamanouchi; Akiko Kashiwabara; Tomomi Inoue; T Yoshimura; S Fujimori; T Tanabe; Y Aiso
The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels.
Diabetes research and clinical practice 2000;50(2):97-101.
2000: Toshikazu Yamanouchi; Nobuyuki Ogata; T Yoshimura; Tomomi Inoue; E Ogata; Takahiro Kawasaki; Akiko Kashiwabara; Hiroe Muraoka
Transport of 1,5-anhydro-D-glucitol into insulinoma cells by a glucose-sensitive transport system.
Biochimica et biophysica acta 2000;1474(3):291-8.
2000: Toshikazu Yamanouchi
[Troglitazone].
Nihon rinsho. Japanese journal of clinical medicine 2000;58(2):389-94.
1999: Toshikazu Yamanouchi
[GAD antibodies, GAD65 antibody].
Nihon rinsho. Japanese journal of clinical medicine 1999;57 Suppl():372-5.
1999: Toshikazu Yamanouchi
[1,5-Anhydroglucitol (1,5AG)].
Nihon rinsho. Japanese journal of clinical medicine 1999;57 Suppl():628-30.
1999: Toshikazu Yamanouchi
[Insulin-sensitizing agent].
Nihon rinsho. Japanese journal of clinical medicine 1999;57(3):675-80.
1998: Toshikazu Yamanouchi; Takahiro Kawasaki; T Yoshimura; Tomomi Inoue; E Koshibu; Nobuyuki Ogata; H Funato; I Akaoka; H Miyashita
Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
Diabetes care 1998;21(4):619-24.
1998: Toshikazu Yamanouchi; N Sekino; T Yoshimura; Takahiro Kawasaki; E Koshibu; Tomomi Inoue; H Funato; Nobuyuki Ogata; H Miyashita
Acute glucosuria after continuous glucocorticoid loading in the rat in vivo.
European journal of pharmacology 1998;341(2-3):257-63.
1998: Toshikazu Yamanouchi
[1,5-Anhydroglucitol (1,5AG)].
Nihon rinsho. Japanese journal of clinical medicine 1998;56 Suppl 3():68-73.
1996: Toshikazu Yamanouchi; T Shinohara; Nobuyuki Ogata; Y Tachibana; I Akaoka; H Miyashita
Common reabsorption system of 1,5-anhydro-D-glucitol, fructose, and mannose in rat renal tubule.
Biochimica et biophysica acta 1996;1291(1):89-95.
1996: Toshikazu Yamanouchi; Nobuyuki Ogata; T Tagaya; Takahiro Kawasaki; N Sekino; H Funato; L Akaoka; H Miyashita
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.
Lancet 1996;347(9014):1514-8.
1995: Toshikazu Yamanouchi; I Akaoka
[Hyperuric acidemia and obesity].
Nihon rinsho. Japanese journal of clinical medicine 1995;53 Suppl():310-5.
1995: Toshikazu Yamanouchi
[1,5-Anhydroglucitol (1,5 AG)].
Nihon rinsho. Japanese journal of clinical medicine 1995;53 Su Pt 1():553-6.
1995: Toshikazu Yamanouchi; S Minoda; Nobuyuki Ogata; Y Tachibana; N Sekino; H Miyashita; I Akaoka
Prolonged hyperalimentation as a possible cause of renal tubular dysfunction: evaluation of 1,5-anhydro-D-glucitol resorption and N-acetylglucosaminidase excretion in humans.
Clinical science (London, England : 1979) 1995;88(2):203-10.
1994: Toshikazu Yamanouchi; Yasuo Akanuma
Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
Diabetes research and clinical practice 1994;24 Suppl():S261-8.
1994: Toshikazu Yamanouchi; H Moromizato; S Kojima; T Shinohara; N Sekino; S Minoda; H Miyashita; I Akaoka
Prevention of diabetes by thymic hormone in alloxan-treated rats.
European journal of pharmacology 1994;257(1-2):39-46.
1994: Toshikazu Yamanouchi; Y Tachibana; N Sekino; H Akanuma; I Akaoka; H Miyashita
Transport and accumulation of 1,5-anhydro-D-glucitol in the human erythroleukemia cell line K-562.
The Journal of biological chemistry 1994;269(13):9664-8.
1993: I Akaoka; Y Ito; Toshikazu Yamanouchi; Shin Fujimori
[Hyperuricemia].
Nihon rinsho. Japanese journal of clinical medicine 1993;51 Suppl():340-6.
1992: Toshikazu Yamanouchi; H Moromizato; T Shinohara; S Minoda; H Miyashita; I Akaoka
Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
Metabolism: clinical and experimental 1992;41(8):862-7.
1992: Toshikazu Yamanouchi; Y Tachibana; H Akanuma; S Minoda; T Shinohara; H Moromizato; H Miyashita; I Akaoka
Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body.
The American journal of physiology 1992;263(2 Pt 1):E268-73.
1991: I Akaoka; Shin Fujimori; Toshikazu Yamanouchi
[Epidemiology of hyperuricemia and gout: difference between Caucasians and Japanese].
Nihon rinsho. Japanese journal of clinical medicine 1991;49(5):989-93.
1991: Toshikazu Yamanouchi; I Akaoka
[The genetic basis of hyperuricemia due to a decrease in renal urate secretion].
Nihon rinsho. Japanese journal of clinical medicine 1991;49(5):1055-9.
1991: Shin Fujimori; Toshikazu Yamanouchi; I Akaoka
[HPRT deficiency].
Nihon rinsho. Japanese journal of clinical medicine 1991;49(5):1036-42.
1990: Toshikazu Yamanouchi; I Akaoka
[Clinical significance of plasma 1,5-anhydroglucitol analysis in the diagnosis of diabetes mellitus].
Nihon rinsho. Japanese journal of clinical medicine 1990;48 Suppl():374-80.
1990: Toshikazu Yamanouchi; I Akaoka; Yasuo Akanuma; H Akanuma; E Miyashita
Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents.
The American journal of physiology 1990;258(3 Pt 1):E423-7.
1989: Toshikazu Yamanouchi; S Minoda; M Yabuuchi; Yasuo Akanuma; H Akanuma; H Miyashita; I Akaoka
Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Diabetes 1989;38(6):723-9.
1988: Toshikazu Yamanouchi; H Akanuma; T Nakamura; I Akaoka; Yasuo Akanuma
Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.
Diabetologia 1988;31(1):41-5.
1987: Toshikazu Yamanouchi; H Akanuma; T Asano; C Konishi; I Akaoka; Yasuo Akanuma
Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus.
Diabetes 1987;36(6):709-15.